JNPR vs ZBIO · P/E 38, $13.36B cap vs rev $10.0M
Juniper Networks Inc (JNPR) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Juniper Networks Inc (JNPR) is a communication equipment company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
JNPR does not have a complete income-statement cache yet.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
JNPR currently screens at market cap $13.36B and trailing P/E 38.0. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the JNPR and ZBIO stock pages for the full models.
Not investment advice.